Clinical Ex Vivo Lung Perfusion
Does ex vivo lung perfusion have the capacity to make unacceptable donor lungs acceptable for recipients?
Category : Organ Transplants & Donation : Health & Medical
Lung Transplantation in Infants and Toddlers from 1990 to 2004
Outcomes of infants and toddlers undergoing lung transplantation are compared with outcomes in older children transplanted for similar pathophysiologies.
Donor-Derived Disease Transmissions -- Is Better Information at Hand?
Is our information about the number of donor-derived disease transmissions after kidney transplantation sufficient?
Advances in Intestinal Transplantation
Refinements in operative techniques, postoperative management, and immunosuppressive therapy improve outcomes in intestinal transplantation.
Valganciclovir Versus IV Ganciclovir
The VICTOR trial is an important step in showing that oral valganciclovir is effective in the treatment of CMV disease, but it is not yet time to declare victory over CMV disease.
Ask the Experts - Liver Transplantation for Homozygous Protein C...
Is liver transplantation a treatment for homozygous protein C deficiency in a child?
Ask the Experts - Gastric Carcinoma After Renal Transplantation?
A 48-year old female received a haploidentical kidney transplant 18 months ago. During a recent evaluation for dyspepsia, an upper endoscopic examination showed a gastric ulcer and a biopsy detected gastric carcinoma.
Mortality and CV Disease Among Older Live Kidney Donors
What do living kidney donors give up when they give the gift of life?
A Guidance Document From the AST's Living Donor Community of Practice
Find out about 7 recommendations to clarify and optimize the Independent Living Donor Advocate role and more.
Issues in Hepatitis C Virus-Positive Liver and Kidney Transplant Recipients
A surprising issue that has recently emerged from studies of liver transplantation in Hepatitis C infected liver and kidney transplant patients is the heightened risk for new onset diabetes.
2nd International Conference on Transplant Infectious Disease
Defensive strategies such as assays for early detection and monitoring, prophylaxis, and preemptive therapy are needed to combat infectious complications, a major cause of morbidity and mortality after transplantation.
Ask the Experts - Angiotensin-Converting Enzyme Inhibitors?
Do angiotensin-converting enzyme inhibitors have a renal protective effect in nondiabetic nephropathies?
Pancreas Allocation for Whole Organ and Islet Transplantation
Learn more about factors that impact waiting time for pancreas and islet cell transplants.
Donor-Derived Fungal Infections in Organ Transplant
Donor-derived fungal infections can be associated with serious complications in transplant recipients. How can they be curtailed?
Kidney Allocation in Liver Transplant Candidates With Renal Failure
In this video blog Ron Shapiro, MD discusses the results of a study of the feasibility, value, and risk of percutaneous renal biopsy in liver transplant candidates with renal failure.
Transplanting Kidneys From Deceased Donors With Severe AKI
What factors influence success with kidneys transplanted from deceased donors with AKI?
Lung Transplantation in Patient With Scleroderma
Is this patient a suitable candidate for lung/heart transplantation?
Antibody-Mediated Rejection After SKPT
In one of the first reports of AMR in SKPT, the authors document the clinical significance of positive C4d immunostaining in renal allograft biopsies in SKPT recipients with graft dysfunction.
Ask the Experts - Age Limit for Kidney Donors?
Living kidney donors usually range in age from 18-60 years, although there is limited experience beyond this range.
Future Direction of the Adult Heart Allocation System in US
Learn how OPTN/UNOS proposed changes to the heart allocation system can provide a framework for more effective and equitable allocation of organs.